Ascitis and renal disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Portal hypertension in liver disease leads to increased hydrostatic pressure in the portal venous system, causing fluid to leak into the abdominal cavity, resulting in ascites.

• Secondary mechanism: In renal disease, reduced kidney function impairs sodium and water excretion, contributing to fluid overload and exacerbating ascites.

• Key complication: Ascites increases abdominal pressure, potentially leading to respiratory issues and reduced renal perfusion, further worsening renal function.

Patient Profile

Demographics:

55-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease (Stage 3)

• Current medications: Lisinopril, Metformin, Furosemide, Spironolactone

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal distention and discomfort

• Key symptoms: Abdominal bloating, peripheral edema, fatigue, decreased urine output

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C, oxygen saturation 94% on room air

Section 1

Initial Assessment Findings:

Upon conducting a thorough initial assessment, the nurse notes that the patient's abdominal distention has progressed, with the abdominal girth measuring 110 cm, an increase from the previous assessment. The abdomen is tense and demonstrates positive shifting dullness, confirming the presence of significant ascites. The patient reports increased discomfort and difficulty breathing, particularly when lying flat, indicating possible diaphragmatic elevation due to the fluid accumulation. Peripheral edema is evident, with pitting edema present in the lower extremities up to the knees.

Heart sounds are regular but slightly tachycardic, correlating with the elevated heart rate of 98 bpm. Lung auscultation reveals diminished breath sounds at the bases, suggesting possible pleural effusion secondary to the ascites. The patient's oxygen saturation has decreased to 92% on room air, prompting the need for supplemental oxygen to maintain adequate oxygenation. The patient's reduced urine output, now approximately 250 mL over the past 24 hours, raises concern for worsening renal function.

Laboratory tests reveal a serum creatinine level of 2.5 mg/dL, increased from 2.0 mg/dL previously, and a blood urea nitrogen (BUN) of 55 mg/dL, indicating further deterioration of renal function. Serum albumin is low at 2.8 g/dL, reflecting poor protein status and contributing to fluid retention. Electrolyte imbalances are also noted, with hyponatremia (sodium level of 130 mmol/L) and hypokalemia (potassium level of 3.2 mmol/L), likely exacerbated by diuretic therapy. These findings suggest a need to reevaluate the current medication regimen and consider alternative strategies to manage fluid overload and support renal function while addressing the patient's respiratory compromise.

Section 2

Following the initial assessment findings, the healthcare team decided to conduct further diagnostic evaluations to better understand the patient's current status and guide appropriate interventions. An abdominal ultrasound was performed, confirming the presence of massive ascites. Additionally, the ultrasound revealed early signs of liver congestion, likely stemming from the underlying renal disease and fluid overload. A chest X-ray was obtained to assess the respiratory compromise, which showed bilateral pleural effusions, more pronounced on the right side. This finding further corroborates the hypothesis of fluid transudation due to elevated pressures and reduced oncotic pressure.

The patient's blood pressure remained stable at 128/76 mmHg, but the heart rate increased slightly to 102 bpm, indicating a compensatory response to maintain cardiac output in the face of fluid shifts and decreased oxygenation. The team initiated a low-flow oxygen therapy at 2 L/min via nasal cannula, which improved the patient's oxygen saturation to 95%. In light of the decreasing renal function and electrolyte imbalances, the nephrology team recommended careful titration of diuretic therapy, with a shift from loop diuretics to a combination regimen including spironolactone to address the hypokalemia and assist in fluid management.

As the team proceeded with these interventions, the patient's status was closely monitored for potential complications such as electrolyte disturbances or worsening renal perfusion. The patient's fluid intake was restricted, and a salt-restricted diet was implemented to mitigate further fluid retention. Moving forward, the healthcare team planned to reassess the patient's response to these changes, particularly focusing on urine output, renal function tests, and electrolyte levels. These measures aim to stabilize fluid balance, improve respiratory function, and prevent further deterioration, while providing a comprehensive approach to managing the complex interplay of ascites and renal disease.

Section 3

As the medical team continued to monitor the patient's progress, a new complication arose: the patient began to exhibit signs of hepatic encephalopathy. This was characterized by episodes of confusion and disorientation, which were particularly evident during the evening assessment. The nursing staff noted that the patient, who had been oriented to person, place, and time, now struggled to remember recent events and showed asterixis, or flapping tremor of the hands. Laboratory tests conducted to investigate these symptoms revealed an elevated ammonia level of 75 µmol/L, suggesting impaired liver function and contributing to the altered mental status.

In response to these developments, the healthcare team prioritized interventions to address this new complication. Lactulose therapy was initiated to reduce ammonia levels by enhancing its excretion through the gastrointestinal tract. The patient's mental status was closely monitored, with frequent neurological assessments incorporated into the care plan. Additionally, the team maintained vigilance for any further signs of deterioration, such as worsening confusion or somnolence, which could indicate the need for more aggressive treatment.

Despite the therapeutic measures taken, the patient's renal function continued to decline, as indicated by an increase in serum creatinine to 2.8 mg/dL and a decrease in glomerular filtration rate (GFR) to 25 mL/min. This necessitated further discussions with the nephrology team to evaluate the potential need for renal replacement therapy should the patient's condition continue to worsen. The integration of these findings underscores the complexity of managing the interconnected issues of liver and renal dysfunction, necessitating a multidisciplinary approach to optimize patient outcomes. Moving forward, the team planned to reassess the effectiveness of the current interventions and adjust the treatment regimen as necessary to stabilize the patient's condition.

Section 4

As the days progressed, the patient's condition exhibited further changes, leading to new diagnostic results that required careful interpretation and clinical reasoning. Repeat laboratory tests revealed a concerning trend: the patient's ammonia levels, despite lactulose therapy, had only marginally decreased to 70 µmol/L. This suboptimal response suggested the need for reassessment of the current dosing regimen and potentially exploring additional therapeutic options. Meanwhile, liver function tests showed an increase in total bilirubin to 3.5 mg/dL and a marked elevation in alanine aminotransferase (ALT) to 90 U/L, indicating ongoing liver inflammation and dysfunction. These findings prompted the healthcare team to consider the possibility of progressive liver damage contributing to hepatic encephalopathy and worsening renal impairment.

Further complicating the clinical picture, an abdominal ultrasound was performed to evaluate the extent of ascites and revealed moderate ascitic fluid accumulation with signs of portal hypertension. This finding raised the concern for potential spontaneous bacterial peritonitis (SBP), a common and serious complication in patients with ascites. To rule out this possibility, a diagnostic paracentesis was performed, yielding a peritoneal fluid analysis with a white blood cell count of 350 cells/mm³ and a polymorphonuclear leukocyte (PMN) count of 250 cells/mm³, suggesting possible infection. Cultures were sent to identify any bacterial growth, necessitating the initiation of broad-spectrum antibiotics empirically to preemptively address any potential infectious process.

These evolving diagnostic results highlighted the intricate interplay between liver and renal dysfunction, emphasizing the need for an integrated management strategy. The healthcare team faced the challenge of balancing interventions to manage hepatic encephalopathy, ascites, and potential infection while closely monitoring renal function. The nephrology team was consulted to explore renal support options, including possible initiation of renal replacement therapy, given the persistent decline in renal function. As the patient's status remained precarious, the multidisciplinary team continued to adapt the care plan, aiming to stabilize the patient and prevent further complications, all while preparing for the next phase of the patient's complex medical journey.

Section 5

As the healthcare team concentrated on managing the patient's complex condition, a change in patient status emerged, indicating a potential shift in the clinical picture. The patient began to exhibit signs of worsening hepatic encephalopathy, characterized by increased confusion, disorientation, and asterixis, despite ongoing lactulose therapy. Vital signs revealed a mild fever of 100.8°F, a blood pressure of 110/70 mmHg, and a heart rate of 98 beats per minute, which aligned with the suspicion of an infectious process. Additionally, the patient reported mild abdominal discomfort, and there was a noticeable increase in abdominal distension, further complicating the situation.

In response to these developments, the team prioritized the management of hepatic encephalopathy and the suspected infection. Given the marginal decrease in ammonia levels and the patient's cognitive decline, the dosing of lactulose was reassessed, leading to an increase in frequency to enhance ammonia clearance. Concurrently, the empirical antibiotic therapy was adjusted based on the initial culture sensitivities, targeting the likely pathogens responsible for the suspected spontaneous bacterial peritonitis. Close monitoring of the patient's renal function continued, with serum creatinine levels noted at 2.3 mg/dL, suggesting a gradual decline necessitating consideration of renal support measures.

The evolving clinical scenario underscored the need for vigilant monitoring and prompt intervention to prevent further deterioration. The healthcare team remained focused on stabilizing the patient's condition, mindful of the delicate balance required to address hepatic and renal dysfunction concurrently. As they awaited further culture results and observed the patient's response to the adjusted interventions, the team prepared for potential escalation of care, including the consideration of renal replacement therapy, should the patient's renal function continue to decline. This proactive approach aimed to mitigate the risk of additional complications and guide the patient toward recovery.